Bio Rad Laboratories, Inc. financial data

Symbol
BIO, BIO-B on NYSE
Industry
Laboratory Analytical Instruments
Location
1000 Alfred Nobel Drive, Hercules, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 622 % +6.77%
Quick Ratio 161 % +10.1%
Debt-to-equity 42.4 % +4.02%
Return On Assets -22.1 % -736%
Operating Margin 9.76 % -20.6%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 27.9M shares -2.02%
Weighted Average Number of Shares Outstanding, Diluted 28M shares -2.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.54B USD -2.46%
Research and Development Expense 303M USD +26.9%
Operating Income (Loss) 248M USD -22.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.75B USD -520%
Income Tax Expense (Benefit) -586M USD -383%
Net Income (Loss) Attributable to Parent -2.16B USD -571%
Earnings Per Share, Basic -76.2 USD/shares -637%
Earnings Per Share, Diluted -76.2 USD/shares -636%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 521M USD +20.3%
Accounts Receivable, after Allowance for Credit Loss, Current 425M USD -4.52%
Inventory, Net 790M USD +0.86%
Other Assets, Current 36M USD -7.17%
Assets, Current 3.04B USD -0.8%
Property, Plant and Equipment, Net 528M USD -0.17%
Operating Lease, Right-of-Use Asset 153M USD -18.9%
Intangible Assets, Net (Excluding Goodwill) 296M USD -5.58%
Goodwill 415M USD +0.43%
Other Assets, Noncurrent 102M USD +7.38%
Assets 9.53B USD -24.4%
Accounts Payable, Current 138M USD +34.2%
Employee-related Liabilities, Current 157M USD +7.45%
Liabilities, Current 507M USD +8.68%
Long-term Debt and Lease Obligation 1.2B USD +0.11%
Deferred Income Tax Liabilities, Net 841M USD -45.4%
Operating Lease, Liability, Noncurrent 126M USD -21%
Other Liabilities, Noncurrent 173M USD -10%
Liabilities 2.85B USD -20%
Accumulated Other Comprehensive Income (Loss), Net of Tax -410M USD +3.8%
Retained Earnings (Accumulated Deficit) 7.48B USD -22.4%
Stockholders' Equity Attributable to Parent 6.68B USD -26.2%
Liabilities and Equity 9.53B USD -24.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 130M USD +86.1%
Net Cash Provided by (Used in) Financing Activities -97.7M USD
Net Cash Provided by (Used in) Investing Activities 2.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 33.3M USD +13.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 523M USD +20.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.2M USD -0.89%
Deferred Tax Assets, Valuation Allowance 95.2M USD +78.9%
Deferred Tax Assets, Gross 251M USD -4.92%
Operating Lease, Liability 168M USD -16.1%
Payments to Acquire Property, Plant, and Equipment 34.4M USD -14.4%
Lessee, Operating Lease, Liability, to be Paid 189M USD -17.6%
Property, Plant and Equipment, Gross 1.64B USD +2.61%
Operating Lease, Liability, Current 41.3M USD +3.15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 29.6M USD -14.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 38.3M USD -17.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.2M USD -27.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22.4M USD -17.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 7.5M shares 0%
Unrecognized Tax Benefits 87.7M USD +1.86%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18.3M USD -14.9%
Operating Lease, Payments 42.9M USD +2.14%
Additional Paid in Capital 476M USD +2.83%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20.7M USD -11.2%
Deferred Tax Assets, Net of Valuation Allowance 156M USD -26.1%
Interest Expense 48.6M USD -1.55%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares